Praxis Precision Medicines listed its shares on the Nasdaq stock exchange on July 17, 2026.
6 reports, 2 independent
Updated Tue 00:00
Still developing
- Reports
- 6
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Praxis Precision Medicines listed its shares on the Nasdaq stock exchange on July 17, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Raymond James raised price target and buy rating for Praxis Precision Medicines.1 source
Stock up $50.93; enrollment exceeded target for supplemental FDA filing.1 source
Praxis Precision Medicines listed on Nasdaq.1 source
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
- Ongoing conflict in the Middle East is causing energy shocks, driving policy decisions, and leading to market exuberance affecting companies like Nvidia and those listed on Nasdaq.
- Sovereign wealth funds from Qatar and Saudi Arabia are investing in global technology and enabling record listings on Nasdaq.
Related events
- Decoy Therapeutics was listed on the Nasdaq stock exchange on September 22, 2026.
- Ironwood Pharmaceuticals listed its shares on the electronic stock exchange on September 8, 2026.
- Generate Biomedicines Inc listed its shares on the Nasdaq stock exchange on August 25, 2026.
- ProKidney and Cartesian Therapeutics were listed on the Nasdaq stock exchange and received ratings from MarketBeat.
- Tempest Therapeutics, Inc. listed its shares on the Nasdaq electronic stock exchange on July 1, 2026.